drugset / Trial / NCT02680314

Is More Than One Dose of Misoprostol Needed to Expedite Vaginal Delivery in a Patient With an Unripe Cervix?

NCT02680314

Phase 2 Completed 243 enrolled Montefiore Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this study is to determine whether inducing labor with just one dose of misoprostol, followed by treatment with oxytocin, will still be effective enough to increase the chances of having a successful vaginal delivery as compared to using more than one dose of misoprostol, followed by treatment with oxytocin.

Timeline

Start
2016-02
Primary completion
2017-05-17
Completion
2021-06-16

Drugs

EvaluationDrugModalityDoseRoute
Comparator Misoprostol Other / unclassified 25 ug Other

Indications

No indication recorded.